Richard S. Finn, MD

GI Oncology Now

<p>Richard Finn, MD, medical oncologist at the Geffen School of Medicine at UCLA, previews key abstracts in hepatobiliary malignancies from the 2025 ASCO Gastrointestinal Cancers Symposium. Dr. Finn reviews updates on pivotal trials, including the ACCELERATE study in resected gallbladder cancer, groundbreaking research in early-stage liver cancer like the LEAP-012 study, and new findings on systemic treatments in advanced liver cancer. Stay tuned for insights on immunotherapy combinations, novel therapeutic strategies, and data that could shape the future of liver cancer care.</p>


Kimberly Perez, MD

Targeting VEGF Pathways in Advanced NETs: Ramucirumab Plus Somatostatin Analog Therapy

GEP-NETs

Jessica Ganga

Adjuvant Chemoradiation, IO for Resectable Biliary Tract Cancers

Bile Duct Cancer

Sakti Chakrabarti, MD

Nonoperative Care for dMMR Rectal Cancer and New Frontlines in Anal Cancer

Colorectal Cancer

Latest News

Top Liver Cancer Abstracts to Watch at ASCO GI 2025

Liver Cancer

Dr. Finn previews key abstracts in liver cancer and other hepatobiliary malignancies from ASCO GI 2025.